These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24829194)

  • 21. Serum HE4 as a diagnostic and prognostic marker for lung cancer.
    Iwahori K; Suzuki H; Kishi Y; Fujii Y; Uehara R; Okamoto N; Kobayashi M; Hirashima T; Kawase I; Naka T
    Tumour Biol; 2012 Aug; 33(4):1141-9. PubMed ID: 22373583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Human Epididymis Protein-4 (HE4) - A novel Approach to Differentiate Malignant Frombenign Breast Tumors.
    Sai Baba KSS; Rehman MA; Pradeep Kumar J; Fatima M; Raju GSN; Uppin SG; Mohammed N
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2509-2507. PubMed ID: 34452565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125.
    Zheng X; Chen S; Li L; Liu X; Liu X; Dai S; Zhang P; Lu H; Lin Z; Yu Y; Li G
    J Gynecol Obstet Hum Reprod; 2018 Jun; 47(6):227-230. PubMed ID: 29609043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined detection of sialic acid and hydroxyproline in diagnosis of ovarian cancer and its comparison with human epididymis protein 4 and carbohydrate antigen 125.
    Li PL; Zhang X; Li TF; Wang LL; Du LT; Yang YM; Li J; Wang HY; Zhang Y; Wang CX
    Clin Chim Acta; 2015 Jan; 439():148-53. PubMed ID: 25445414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors.
    Haltia UM; Hallamaa M; Tapper J; Hynninen J; Alfthan H; Kalra B; Ritvos O; Heikinheimo M; Unkila-Kallio L; Perheentupa A; Färkkilä A
    Gynecol Oncol; 2017 Jan; 144(1):83-89. PubMed ID: 27871721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revised Cut-Off Value of Human Epididymis Protein 4 Enhances Its Use as an Ovarian Tumor Marker.
    Machida H; Hirakawa T; Tsunekawa K; Kimura T; Murakami M; Abe Y
    Gynecol Obstet Invest; 2023; 88(6):349-358. PubMed ID: 37788640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of HE4 for ovarian cancer: a meta-analysis.
    Yu S; Yang HJ; Xie SQ; Bao YX
    Clin Chem Lab Med; 2012 Feb; 50(8):1439-46. PubMed ID: 22868811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population.
    Kim YM; Whang DH; Park J; Kim SH; Lee SW; Park HA; Ha M; Choi KH
    Clin Chem Lab Med; 2011 Mar; 49(3):527-34. PubMed ID: 21320028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward?
    Azzam AZ; Hashad DI; Kamel NA
    Arch Gynecol Obstet; 2013 Jul; 288(1):167-72. PubMed ID: 23361457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren's Syndrome.
    Chen J; Sun F; Bao H; Liang L; Zhan M; Yao H; He J; Liu Y
    Front Immunol; 2021; 12():670642. PubMed ID: 34248951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of individual biology in the clinical use of serum biomarkers for ovarian cancer.
    Braga F; Ferraro S; Mozzi R; Panteghini M
    Clin Chem Lab Med; 2014 Nov; 52(11):1625-31. PubMed ID: 24829196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression.
    Yamashita S; Tokuishi K; Moroga T; Yamamoto S; Ohbo K; Miyahara S; Yoshida Y; Yanagisawa J; Hamatake D; Hiratsuka M; Yoshinaga Y; Shiraishi T; Iwasaki A; Kawahara K
    Tumour Biol; 2012 Dec; 33(6):2365-70. PubMed ID: 23001907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.
    Anderson KS; Wong J; Vitonis A; Crum CP; Sluss PM; Labaer J; Cramer D
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):859-68. PubMed ID: 20200435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
    Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
    Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study.
    Capriglione S; Plotti F; Miranda A; Ricciardi R; Scaletta G; Aloisi A; Guzzo F; Montera R; Angioli R
    Tumour Biol; 2015 Jun; 36(6):4151-6. PubMed ID: 25577252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging.
    Minar L; Klabenesova I; Jandakova E; Zlamal F; Bienertova-Vasku J
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1644-52. PubMed ID: 26223178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients.
    Omer B; Genc S; Takmaz O; Dirican A; Kusku-Kiraz Z; Berkman S; Gurdol F
    Tumour Biol; 2013 Oct; 34(5):2645-50. PubMed ID: 23640061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer.
    Zhang T; Chu L; Tan W; Ye C; Dong H
    Clin Respir J; 2024 May; 18(5):e13774. PubMed ID: 38742362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer.
    Knific T; Osredkar J; Smrkolj Š; Tonin I; Vouk K; Blejec A; Frković Grazio S; Rižner TL
    Gynecol Oncol; 2017 Oct; 147(1):126-132. PubMed ID: 28735628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of DJ-1 and HE4 in patients with endometrial cancer.
    Benati M; Montagnana M; Danese E; Paviati E; Giudici S; Ruzzenente O; Franchi M; Lippi G
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.